FDA warns against using Cardinal’s syringes, pain-control pumps

Share This
FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland

(Reuters) – The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal Health’s Monoject syringes with patient-controlled pain management pumps.

The regulator’s warning comes after Cardinal Health initiated a recall for the Monoject syringes due to incompatibility concerns with syringe pumps.

Monoject-control syringes are sterile, single-use syringes without a needle while patient-controlled analgesia or pain management pumps are used to treat different kinds of pain by transferring medications intravenously.

(Reporting by Christy Santhosh; Editing by Maju Samuel)

- Advertisement -